
Lien M. Ngo
Examiner (ID: 14795, Phone: (571)272-4545 , Office: P/3754 )
| Most Active Art Unit | 3754 |
| Art Unit(s) | 3731, 3727, 3754 |
| Total Applications | 2364 |
| Issued Applications | 1588 |
| Pending Applications | 131 |
| Abandoned Applications | 652 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18466980
[patent_doc_number] => 20230201260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPHY
[patent_app_type] => utility
[patent_app_number] => 18/056544
[patent_app_country] => US
[patent_app_date] => 2022-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056544
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/056544 | METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPHY | Nov 16, 2022 | Pending |
Array
(
[id] => 18391675
[patent_doc_number] => 20230159893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => ANTIGEN PRESENTING T CELLS, SENSITIZED, MANUFACTURED T CELLS AND METHODS OF TREATMENT USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/984810
[patent_app_country] => US
[patent_app_date] => 2022-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62106
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17984810
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/984810 | ANTIGEN PRESENTING T CELLS, SENSITIZED, MANUFACTURED T CELLS AND METHODS OF TREATMENT USING THE SAME | Nov 9, 2022 | Pending |
Array
(
[id] => 18693034
[patent_doc_number] => 20230323419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => VERTEBRATE CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A POLYPEPTIDE OF INTEREST
[patent_app_type] => utility
[patent_app_number] => 17/973773
[patent_app_country] => US
[patent_app_date] => 2022-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17973773
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/973773 | VERTEBRATE CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A POLYPEPTIDE OF INTEREST | Oct 25, 2022 | Pending |
Array
(
[id] => 18595984
[patent_doc_number] => 20230270774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => TAU MODULATORS AND METHODS AND COMPOSITIONS FOR DELIVERY THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/046327
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30327
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046327
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046327 | TAU MODULATORS AND METHODS AND COMPOSITIONS FOR DELIVERY THEREOF | Oct 12, 2022 | Pending |
Array
(
[id] => 18177377
[patent_doc_number] => 20230038106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM
[patent_app_type] => utility
[patent_app_number] => 17/932812
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44682
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17932812
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/932812 | METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM | Sep 15, 2022 | Abandoned |
Array
(
[id] => 18161089
[patent_doc_number] => 20230027681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => METHOD OF INCREASING THE REPLICATION OF A CIRCULAR DNA MOLECULE
[patent_app_type] => utility
[patent_app_number] => 17/932026
[patent_app_country] => US
[patent_app_date] => 2022-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24057
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17932026
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/932026 | METHOD OF INCREASING THE REPLICATION OF A CIRCULAR DNA MOLECULE | Sep 13, 2022 | Pending |
Array
(
[id] => 18321722
[patent_doc_number] => 20230119850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => LIVER-SPECIFIC CONSTRUCTS, FACTOR VIII EXPRESSION CASSETTES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/929157
[patent_app_country] => US
[patent_app_date] => 2022-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24136
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929157
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929157 | LIVER-SPECIFIC CONSTRUCTS, FACTOR VIII EXPRESSION CASSETTES AND METHODS OF USE THEREOF | Aug 31, 2022 | Abandoned |
Array
(
[id] => 18469196
[patent_doc_number] => 20230203480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => LIPID NANOPARTICLE FORMULATIONS FOR CRISPR/CAS COMPONENTS
[patent_app_type] => utility
[patent_app_number] => 17/897878
[patent_app_country] => US
[patent_app_date] => 2022-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17897878
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/897878 | LIPID NANOPARTICLE FORMULATIONS FOR CRISPR/CAS COMPONENTS | Aug 28, 2022 | Pending |
Array
(
[id] => 18080823
[patent_doc_number] => 20220406435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => METHODS OF TREATING DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE WITH PROTECTIVE PROTEIN/CATHEPSIN A (PPCA)
[patent_app_type] => utility
[patent_app_number] => 17/820755
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820755
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820755 | METHODS OF TREATING DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE WITH PROTECTIVE PROTEIN/CATHEPSIN A (PPCA) | Aug 17, 2022 | Pending |
Array
(
[id] => 18902995
[patent_doc_number] => 20240018480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => ENHANCEMENT OF EXTRACELLULAR VESICLE PRODUCTION BY LYSOSOME INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/866404
[patent_app_country] => US
[patent_app_date] => 2022-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17866404
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/866404 | ENHANCEMENT OF EXTRACELLULAR VESICLE PRODUCTION BY LYSOSOME INHIBITOR | Jul 14, 2022 | Pending |
Array
(
[id] => 18036521
[patent_doc_number] => 20220380736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM
[patent_app_type] => utility
[patent_app_number] => 17/858885
[patent_app_country] => US
[patent_app_date] => 2022-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44581
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17858885
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/858885 | METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM | Jul 5, 2022 | Abandoned |
Array
(
[id] => 18056445
[patent_doc_number] => 20220387531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM
[patent_app_type] => utility
[patent_app_number] => 17/858899
[patent_app_country] => US
[patent_app_date] => 2022-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17858899
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/858899 | METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM | Jul 5, 2022 | Abandoned |
Array
(
[id] => 18177566
[patent_doc_number] => 20230038295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => ADENO-ASSOCIATED VIRUS PACKAGING SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/808630
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17808630
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/808630 | ADENO-ASSOCIATED VIRUS PACKAGING SYSTEMS | Jun 23, 2022 | Abandoned |
Array
(
[id] => 18034732
[patent_doc_number] => 20220378947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => Hybrid System for Efficient Gene Delivery to Cells of the Inner Ear
[patent_app_type] => utility
[patent_app_number] => 17/848047
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848047
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/848047 | Hybrid System for Efficient Gene Delivery to Cells of the Inner Ear | Jun 22, 2022 | Pending |
Array
(
[id] => 19300512
[patent_doc_number] => 20240229081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => CRISPR-CAS3 SYSTEMS FOR TARGETED GENOME ENGINEERING
[patent_app_type] => utility
[patent_app_number] => 18/563175
[patent_app_country] => US
[patent_app_date] => 2022-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23734
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563175
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/563175 | CRISPR-CAS3 SYSTEMS FOR TARGETED GENOME ENGINEERING | May 25, 2022 | Pending |
Array
(
[id] => 20541201
[patent_doc_number] => 20260048089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-02-19
[patent_title] => G-PROTEIN-GATED-K+ CHANNEL-MEDIATED ENHANCEMENTS IN LIGHT SENSITIVITY IN ROD-CONE DYSTROPHY (RCD)
[patent_app_type] => utility
[patent_app_number] => 18/563959
[patent_app_country] => US
[patent_app_date] => 2022-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563959
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/563959 | G-PROTEIN-GATED-K+ CHANNEL-MEDIATED ENHANCEMENTS IN LIGHT SENSITIVITY IN ROD-CONE DYSTROPHY (RCD) | May 24, 2022 | Pending |
Array
(
[id] => 20158436
[patent_doc_number] => 12385048
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Construct and sequence for enhanced gene expression
[patent_app_type] => utility
[patent_app_number] => 17/749460
[patent_app_country] => US
[patent_app_date] => 2022-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 33652
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17749460
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/749460 | Construct and sequence for enhanced gene expression | May 19, 2022 | Issued |
Array
(
[id] => 17852218
[patent_doc_number] => 20220282260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => DNA VECTORS, TRANSPOSONS AND TRANSPOSASES FOR EUKARYOTIC GENOME MODIFICATION
[patent_app_type] => utility
[patent_app_number] => 17/747646
[patent_app_country] => US
[patent_app_date] => 2022-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17747646
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/747646 | DNA VECTORS, TRANSPOSONS AND TRANSPOSASES FOR EUKARYOTIC GENOME MODIFICATION | May 17, 2022 | Abandoned |
Array
(
[id] => 19331184
[patent_doc_number] => 20240245614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => PRODUCTION OF THERAPEUTIC MESENCHYMAL STEM CELL-DERIVED EXOSOMES
[patent_app_type] => utility
[patent_app_number] => 18/559667
[patent_app_country] => US
[patent_app_date] => 2022-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32118
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -96
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18559667
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/559667 | PRODUCTION OF THERAPEUTIC MESENCHYMAL STEM CELL-DERIVED EXOSOMES | May 16, 2022 | Pending |
Array
(
[id] => 18139362
[patent_doc_number] => 20230013198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => METHODS FOR IN VITRO MEMORY B CELL DIFFERENTIATION AND TRANSDUCTION WITH VSV-G PSEUDOTYPED VIRAL VECTORS
[patent_app_type] => utility
[patent_app_number] => 17/735676
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735676
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/735676 | METHODS FOR IN VITRO MEMORY B CELL DIFFERENTIATION AND TRANSDUCTION WITH VSV-G PSEUDOTYPED VIRAL VECTORS | May 2, 2022 | Abandoned |